63 related articles for article (PubMed ID: 9878423)
1. Modification of retroviral tropism by display of IGF-I.
Chadwick MP; Morling FJ; Cosset FL; Russell SJ
J Mol Biol; 1999 Jan; 285(2):485-94. PubMed ID: 9878423
[TBL] [Abstract][Full Text] [Related]
2. Masking of retroviral envelope functions by oligomerizing polypeptide adaptors.
Morling FJ; Peng KW; Cosset FL; Russell SJ
Virology; 1997 Jul; 234(1):51-61. PubMed ID: 9234946
[TBL] [Abstract][Full Text] [Related]
3. Retroviral vector targeting through insertion of epidermal growth factor into receptor binding deficient influenza A hemagglutinin results in fusion defective particles.
Haynes C; Schnierle BS
J Virol Methods; 2004 Sep; 120(2):189-99. PubMed ID: 15288962
[TBL] [Abstract][Full Text] [Related]
4. Growth factor displayed on the surface of retroviral particles without manipulation of envelope proteins is biologically active and can enhance transduction.
Chandrashekran A; Gordon MY; Darling D; Farzaneh F; Casimir C
J Gene Med; 2004 Nov; 6(11):1189-96. PubMed ID: 15468194
[TBL] [Abstract][Full Text] [Related]
5. Targeting of retroviral vectors through protease-substrate interactions.
Nilson BH; Morling FJ; Cosset FL; Russell SJ
Gene Ther; 1996 Apr; 3(4):280-6. PubMed ID: 8732159
[TBL] [Abstract][Full Text] [Related]
6. A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display.
Fielding AK; Chapel-Fernandes S; Chadwick MP; Bullough FJ; Cosset FL; Russell SJ
Hum Gene Ther; 2000 Apr; 11(6):817-26. PubMed ID: 10779159
[TBL] [Abstract][Full Text] [Related]
7. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
8. Trophic activity of Rabies G protein-pseudotyped equine infectious anemia viral vector mediated IGF-I motor neuron gene transfer in vitro.
Teng Q; Garrity-Moses M; Federici T; Tanase D; Liu JK; Mazarakis ND; Azzouz M; Walmsley LE; Carlton E; Boulis NM
Neurobiol Dis; 2005 Dec; 20(3):694-700. PubMed ID: 16005636
[TBL] [Abstract][Full Text] [Related]
9. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
[TBL] [Abstract][Full Text] [Related]
10. Expression of insulin-like growth factor-1 and insulin-like growth factor-1 receptors in EL4 lymphoma cells overexpressing growth hormone.
Weigent DA; Arnold RE
Cell Immunol; 2005 Mar; 234(1):54-66. PubMed ID: 15964559
[TBL] [Abstract][Full Text] [Related]
11. Redirecting retroviral tropism by insertion of hepatitis B virus PreS1 core peptide into the envelope.
Qi P; Han JX; Lu YQ; Wang CX
Arch Virol; 2007; 152(9):1721-30. PubMed ID: 17520321
[TBL] [Abstract][Full Text] [Related]
12. Two point mutations increase targeted transduction and stabilize vector association of a modified retroviral envelope protein.
Zavorotinskaya T; Albritton LM
Mol Ther; 2001 Mar; 3(3):323-8. PubMed ID: 11273774
[TBL] [Abstract][Full Text] [Related]
13. Effect of IGFBP-3 on IGF- and IGF-analogue-induced insulin-like growth factor-I receptor (IGFIR) signalling.
Devi GR; Graham DL; Oh Y; Rosenfeld RG
Growth Horm IGF Res; 2001 Aug; 11(4):231-9. PubMed ID: 11735239
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells.
Chisalita SI; Nitert MD; Arnqvist HJ
Growth Horm IGF Res; 2006 Aug; 16(4):258-66. PubMed ID: 16914341
[TBL] [Abstract][Full Text] [Related]
15. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
16. Direct interaction of insulin-like growth factor-1 receptor with leukemia-associated RhoGEF.
Taya S; Inagaki N; Sengiku H; Makino H; Iwamatsu A; Urakawa I; Nagao K; Kataoka S; Kaibuchi K
J Cell Biol; 2001 Nov; 155(5):809-20. PubMed ID: 11724822
[TBL] [Abstract][Full Text] [Related]
17. Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein tyrosine phosphatase 1B using bioluminescence resonance energy transfer.
Blanquart C; Boute N; Lacasa D; Issad T
Mol Pharmacol; 2005 Sep; 68(3):885-94. PubMed ID: 15976035
[TBL] [Abstract][Full Text] [Related]
18. Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells.
Scott CD; Weiss J
J Cell Physiol; 2000 Jan; 182(1):62-8. PubMed ID: 10567917
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface.
Robinson SA; Rosenzweig SA
Biochemistry; 2004 Sep; 43(36):11533-45. PubMed ID: 15350139
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I inhibits the progression of human U-2 OS osteosarcoma cells towards programmed cell death through interaction with the IGF-I receptor.
Herzlieb N; Gallaher BW; Berthold A; Hille R; Kiess W
Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):71-7. PubMed ID: 10726973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
